Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Cortesi

Showing results (21-30 of 181) with videos related to

Pageof 19
Sort By:
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|June 10, 2020
The reduction of CA 125 serum levels in BRCA 1/2 mutation carriers after risk-reducing salpingo-oophorectomy is only partially associated with surgery: a prospective cohort, other biomarker controlled, studyGiovanni Grandi, Maria Chiara Del Savio, Margaret Sammarini, et al.
Clinical Breast Cancer|November 19, 2017
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family HistoryGiovanni Grandi, Angela Toss, Angelo Cagnacci, et al.
International Journal of Molecular Sciences|April 18, 2013
Ovarian cancer: can proteomics give new insights for therapy and diagnosis?Angela Toss, Elisabetta De Matteis, Elena Rossi, et al.
Cancers|July 2, 2020
Lifestyle Intervention on Body Weight and Physical Activity in Patients with Breast Cancer can reduce the Risk of Death in Obese Women: The EMILI StudyLaura Cortesi, Federica Sebastiani, Anna Iannone, et al.
Familial Cancer|April 25, 2020
Primary fallopian tube carcinoma (PFTC) in a BRIP-1 mutation carrier: the first case reportGiovanni Grandi, Martina Caroli, Carlo Alboni, et al.
Molecular and Clinical Oncology|May 27, 2020
Male mammary myofibroblastoma: Two case reports and brief review of literatureMarta Venturelli, Angela Toss, Laura Cortesi, et al.
Minerva Medica|May 14, 2019
Hereditary ovarian cancers: state of the artAngela Toss, Eleonora Molinaro, Margaret Sammarini, et al.
Menopause (New York, N.Y.)|November 2, 2021
The challenging screen detection of ovarian cancer in BRCA mutation carriers adhering to a 6-month follow-up program: results from a 6-years surveillanceGiovanni Grandi, Federica Fiocchi, Laura Cortesi, et al.
Drugs & Aging|September 2, 2016
Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI StudyLuca Pasina, Sarah Astuto, Laura Cortesi, et al.
Biomed Research International|June 16, 2015
Hereditary ovarian cancer: not only BRCA 1 and 2 genesAngela Toss, Chiara Tomasello, Elisabetta Razzaboni, et al.
Pageof 19

Showing results (21-30 of 181) with videos related to

Sort By:
Pageof 19
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|June 10, 2020
The reduction of CA 125 serum levels in BRCA 1/2 mutation carriers after risk-reducing salpingo-oophorectomy is only partially associated with surgery: a prospective cohort, other biomarker controlled, studyGiovanni Grandi, Maria Chiara Del Savio, Margaret Sammarini, et al.
Clinical Breast Cancer|November 19, 2017
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family HistoryGiovanni Grandi, Angela Toss, Angelo Cagnacci, et al.
International Journal of Molecular Sciences|April 18, 2013
Ovarian cancer: can proteomics give new insights for therapy and diagnosis?Angela Toss, Elisabetta De Matteis, Elena Rossi, et al.
Cancers|July 2, 2020
Lifestyle Intervention on Body Weight and Physical Activity in Patients with Breast Cancer can reduce the Risk of Death in Obese Women: The EMILI StudyLaura Cortesi, Federica Sebastiani, Anna Iannone, et al.
Familial Cancer|April 25, 2020
Primary fallopian tube carcinoma (PFTC) in a BRIP-1 mutation carrier: the first case reportGiovanni Grandi, Martina Caroli, Carlo Alboni, et al.
Molecular and Clinical Oncology|May 27, 2020
Male mammary myofibroblastoma: Two case reports and brief review of literatureMarta Venturelli, Angela Toss, Laura Cortesi, et al.
Minerva Medica|May 14, 2019
Hereditary ovarian cancers: state of the artAngela Toss, Eleonora Molinaro, Margaret Sammarini, et al.
Menopause (New York, N.Y.)|November 2, 2021
The challenging screen detection of ovarian cancer in BRCA mutation carriers adhering to a 6-month follow-up program: results from a 6-years surveillanceGiovanni Grandi, Federica Fiocchi, Laura Cortesi, et al.
Drugs & Aging|September 2, 2016
Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI StudyLuca Pasina, Sarah Astuto, Laura Cortesi, et al.
Biomed Research International|June 16, 2015
Hereditary ovarian cancer: not only BRCA 1 and 2 genesAngela Toss, Chiara Tomasello, Elisabetta Razzaboni, et al.
Pageof 19